Vagus nerve stimulation (VNS) is a medical treatment in whichelectric impulses are delivered to vagus nerve for the management andtreatment of various types of diseases including epilepsy anddepression. Vagus nerve stimulators are devices used to stimulate thevagus nerve with electrical impulses. Vagus nerve stimulators areclassified in two types: implantable devices and external devices.
The global VagusNerve Stimulators Market is likely to display promisinggrowth in the years ahead. The rising burden of neurological diseasesespecially in emerging countries is a key factor behind the growth ofthis market.Over the past three decades, vagus nerve stimulatortherapy is gaining traction due its high success rate. Vagus nervestimulator therapy has helped reduce the burden of severalneurological conditions such as dyskinesia and neurological tremors,among others. Vagus nerve stimulator creates muscle contraction andis able to overhaul the functionality of motor nerve.
Vagus Nerve Stimulators are widely used in the management andtreatment of diseases such as epilepsy, depression, and migraine.High prevalence of such diseases in key regions is expected to drivevagus nerve stimulators market growth over the forecast period. Forinstance, according to the data published by the National Instituteof Mental Health, depression was one of the most common mentaldisorders in the U.S. in 2016. An estimated 16.2 million adults inthe U.S. had at least one major depressive episode. This numberrepresented 6.7% of all the U.S. adults.
Read More@https://bit.ly/2TzSKAq
